Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia D Cudrici

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Hematology|March 12, 2019
CADASIL: new advances in basic science and clinical perspectivesElisa A Ferrante, Cornelia D Cudrici, Manfred Boehm
Experimental and Molecular Pathology|February 24, 2006
Complement activation in diabetic ketoacidosis brainsWilliam H Hoffman, Cornelia D Cudrici, Ekaterina Zafranskaia, et al.
Experimental and Molecular Pathology|April 16, 2019
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosisWilliam H Hoffman, Cornelia D Cudrici, Dallas Boodhoo, et al.
Clinical Immunology (Orlando, Fla.)|January 10, 2021
Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopeniaCornelia D Cudrici, Afroditi Boulougoura, Virginia Sheikh, et al.
Experimental and Molecular Pathology|March 6, 2007
Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosisWilliam H Hoffman, Manuel F Casanova, Cornelia D Cudrici, et al.
Immunologic Research|October 5, 2014
Role of SIRT1 in autoimmune demyelination and neurodegenerationAlvaro Martin, Cosmin A Tegla, Cornelia D Cudrici, et al.
Immunologic Research|December 19, 2012
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Experimental and Molecular Pathology|November 4, 2009
Epigenetic modifications induced by RGC-32 in colon cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Experimental and Molecular Pathology|September 27, 2015
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosisAdam M Kruszewski, Gautam Rao, Alexandru Tatomir, et al.
Experimental and Molecular Pathology|September 25, 2012
Dual role of Response gene to complement-32 in multiple sclerosisCosmin A Tegla, Cornelia D Cudrici, Philippe Azimzadeh, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|March 12, 2019
CADASIL: new advances in basic science and clinical perspectivesElisa A Ferrante, Cornelia D Cudrici, Manfred Boehm
Experimental and Molecular Pathology|February 24, 2006
Complement activation in diabetic ketoacidosis brainsWilliam H Hoffman, Cornelia D Cudrici, Ekaterina Zafranskaia, et al.
Experimental and Molecular Pathology|April 16, 2019
Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosisWilliam H Hoffman, Cornelia D Cudrici, Dallas Boodhoo, et al.
Clinical Immunology (Orlando, Fla.)|January 10, 2021
Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopeniaCornelia D Cudrici, Afroditi Boulougoura, Virginia Sheikh, et al.
Experimental and Molecular Pathology|March 6, 2007
Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosisWilliam H Hoffman, Manuel F Casanova, Cornelia D Cudrici, et al.
Immunologic Research|October 5, 2014
Role of SIRT1 in autoimmune demyelination and neurodegenerationAlvaro Martin, Cosmin A Tegla, Cornelia D Cudrici, et al.
Immunologic Research|December 19, 2012
Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Experimental and Molecular Pathology|November 4, 2009
Epigenetic modifications induced by RGC-32 in colon cancerSonia I Vlaicu, Cosmin A Tegla, Cornelia D Cudrici, et al.
Experimental and Molecular Pathology|September 27, 2015
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosisAdam M Kruszewski, Gautam Rao, Alexandru Tatomir, et al.
Experimental and Molecular Pathology|September 25, 2012
Dual role of Response gene to complement-32 in multiple sclerosisCosmin A Tegla, Cornelia D Cudrici, Philippe Azimzadeh, et al.
Pageof 2